Basilea Pharmaceutica Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Basilea Pharmaceutica Limited with three other
miscellaneous service companies in Europe:
Oxford BioMedica plc
of the United Kingdom
sales of £66.78 million [US$87.29 million]
of which 82%
(76.44 million Euro [US$84.28 million]
of which 70%
was Proprietary Development), and
Innate Pharma S.A.
based in France
(79.89 million Euro [US$88.08 million]
of which 100%
was Licensing Revenue).
Basilea Pharmaceutica Limited reported sales of 106.09 million Swiss Francs (US$109.26 million)
December of 2018.
increase of 17.0%
versus 2017, when the company's sales were 90.67 million Swiss Francs.
Sales at Basilea Pharmaceutica Limited have increased during each of the previous five years
(and since 2013, sales have increased a total of 159%).